Production of specific antibodies against SARS-coronavirus nucleocapsid protein without cross reactivity with human coronaviruses 229E and OC43

다국어 초록 (Multilingual Abstract)

Severe acute respiratory syndrome (SARS) is a life-threatening disease for which accurate diagnosis is essential. Although many tools have been developed for the diagnosis of SARS, false-positive reactions in negative sera may occur because of cross-reactivity with other coronaviruses. We have raised polyclonal and monoclonal antibodies (Abs) using a recombinant form of the SARS virus nucleocapsid protein. Cross-reactivity of these anti-SARS Abs against human coronavirus (HCoV) 229E and HCoV OC43 were determined by Western blotting. The Abs produced reacted with recombinant SARS virus nucleocapsid protein, but not with HCoV 229E or HCoV OC43.

참고문헌 (Reference)

1 Vlasova AN, "Two-way antigenic crossreactivity between severe acute respiratory syndrome coronavirus (SARS-CoV) and group 1 animal CoVs is mediated through an antigenic site in the N-terminal region of the SARS-CoV nucleoprotein" 81 : 13365-13377, 2007

2 Sizun J, "Survival of human coronaviruses 229E and OC43 in suspension and after drying on surfaces: a possible source of hospital-acquired infections" 46 : 55-60, 2000

3 Che XY, "Sensitive and specific monoclonal antibody-based capture enzyme immunoassay for detection of nucleocapsid antigen in sera from patients with severe acute respiratory syndrome" 42 : 2629-2635, 2004

4 Shin GC, "Preparation and characterization of a novel monoclonal antibody specific to severe acute respiratory syndrome-coronavirus nucleocapsid protein" 122 : 109-118, 2006

5 van der Hoek L, "Identification of a new human coronavirus" 10 : 368-373, 2004

6 Fields BN, "Fields’ Virology" Lippincott Williams & Wilkins 1163-1203, 2001

7 Woo PCY, "Falsepositive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid enzyme-linked immunosorbent assay due to HCoV-OC43 and HCoV-229E rectified by Western blotting with recombinant SARS-CoV spike polypeptide" 42 : 5885-5888, 2004

8 Vabret A, "Direct diagnosis of human respiratory coronaviruses 229E and OC43 by the polymerase chain reaction" 97 : 59-66, 2001

9 이현경, "Detection of Antibodies Against SARS-Coronavirus Using Recombinant Truncated Nucleocapsid Proteins by ELISA" 한국미생물·생명공학회 18 (18): 1717-1721, 2008

10 Peiris JSM, "Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study" 361 : 1767-1772, 2003

11 He Q, "Characterization of monoclonal antibody against SARS coronavirus nucleocapsid antigen and development of an antigen capture ELISA" 127 : 46-53, 2005

12 Rota PA, "Characterization of a novel coronavirus associated with severe acute respiratory syndrome" 300 : 1394-1399, 2003

13 Woo PCY, "Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia" 79 : 884-895, 2005

14 Shang B, "Characterization and application of monoclonal antibodies against N Protein of SARS-coronavirus" 336 : 110-117, 2005